UVA in vivo sunscreen test method urged by Skin Cancer Foundation in comments to FDA.
This article was originally published in The Rose Sheet
Executive Summary
UVA IN VIVO SUNSCREEN TESTING METHOD URGED BY SKIN CANCER FOUNDATION in recent comments to FDA regarding the tentative final monograph for OTC sunscreens. Representing the foundation's photobiology task force, Madhu Pathak, MD, Harvard Medical School, maintains that "in the interest of general consumers and patients sensitive to UVA radiation, the FDA should not eliminate an in vivo method on human volunteers" for determining the UVA protection factor [APF] of UVA sunscreens.